3M Drug Delivery, Spirig Pharma sign agreement; Flexible Stenting Solutions gets 510(k) clearance;

> 3M Drug Delivery Systems has signed an exclusive licensing agreement with Spirig Pharma, a Swiss maker of dermatological products. Spirig will use one of 3M's immune response modifier molecules to further its development of treatment for sun damaged skin. 3M release

> Flexible Stenting Solutions, a New Jersey-based developer of stents, has received 510(k) clearance from the FDA for an improved FlexStent Biliary Self Expanding Stent Delivery System and an expansion of Biliary stent sizes. FSS release

> The World Gold Council is, not surprisingly, quite happy that gold is being used in anti-cancer clinical trials WGC release

> Drug delivery patent application of the week: Oral Drug Delivery System for Azole, Moxifloxacin and Rifampicin Patent application

> Drug delivery abstract of the week: Applications of aptamers in nanodelivery systems in cancer, eye and inflammatory diseases Abstract

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.